Animal's primary focus is on its flagship device. This
technology will enable a physician to isolate a patientís own
antibodies, which can then be labeled with an imaging tag.
The labeled antibodies can be returned to the patient as a
diagnostic and whole-body imaging can be used to visualize the
disease wherever it exists.
labeled antibodies can also be recovered for use in
a variety of rapid and enhanced analytical assays.
This same device can be used to target a therapeutic compound
to the imaged sites resulting in a quantitative drug delivery
method with improved pharmacological properties.
We intend to explore the
application of this technology for several forms of cancer in
The device will be able to monitor progression and regression
of tumors, to locate sites of metastasis and to treat